HAHannah Aryeley Aryee

Hannah Aryeley Aryee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hannah Aryeley Aryee has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Molecular identification of Rickettsia conorii subsp. israelensis and other tick‐borne pathogens in dog ticks from the Upper East region of Ghana

    by Emmanuel Kaba, Seth Offei Addo, Millicent Captain‐Esoah, Selma Nurudeen Salley, Michael E. DeWitt, Bernice Olivia Ama Baako, Elijah D. Angyiereyiri, Kwadwo Kyereme Frempong, Patrick Kwasi Obuam, Ewurabena Oduma Duker, et al.

    Ticks continue to facilitate the spread of pathogens that affect both humans and domestic animals. Domestic dogs interact with humans and other domestic animals, playing a crucial role in the spread of ticks and tick‐borne pathogens. This study examined the diversity of tick species infesting domestic dogs and the occurrence of tick‐borne pathogens in the Upper East region. Domestic dogs were randomly selected and examined for tick infestation. The sampled ticks were morphologically identified, pooled and screened for tick‐borne pathogens using polymerase chain reaction (PCR) and Sanger sequencing. From the 93 dogs examined, all 749 ticks collected were adult Rhipicephalus sanguineus . Out of the 177 tick pools screened, pathogen DNA was detected in 43 pools (24.29%). The identified pathogens were uncultured Anaplasma sp. (14.12%), Ehrlichia canis (7.34%), Rickettsia conorii subsp. israelensis (3.95%) and Coxiella burnetii (2.82%). Factors such as dog age or sex, or tick sex, did not influence the occurrence of a tick‐borne pathogen ( p > 0.05). This study reports the first molecular detection of R. conorii subsp. israelensis in Ghana. The occurrence of zoonotic pathogens suggests an increased risk to dog owners and a need to adopt protective measures to prevent infection spread. These findings highlight the importance of integrated tick control, improved diagnostic capabilities and epidemiological surveillance in Ghana to reduce the burden of tick‐borne diseases on animal and human health.

  • Open Access

    Antibiotics and Antimicrobial Resistance Genes in a Gut Microbiota as a Reservoir—A Review

    by Bismark Dabuo, Abudu Abubakari, Frances Ellen Sankah, Hannah Aryeley Aryee

    The human microbiota is one of the most powerful sites for antibiotic resistance (AR) genes. It is home to thousands of microbes at various stages of development. The complex inner environment has the potential to affect the host’s immunity, metabolism, and genetic makeup. The gut microbiota has an incredibly high level of gene diversity. Its 3.3 million nonredundant genes even outnumber the host’s 150 million total genomes. In the human gut, where 10–100 trillion diversity‐enhanced microbe cells reside, horizontal gene transfer (HGT) is prevalent and occurs at a rate approximately 25 times higher than in any other ecosystem. AR threatens global health by causing stronger infection rates and higher death tolls. The nonmedical setting that aids in the spread of antimicrobial resistance (AMR) is the human microbiome. Antibiotic resistance genes (ARGs) from commensal, anthropogenic, and environmental microbes make up the antibiotic resistome. The evolutionary force from the use of antibiotics in agriculture and medicine increases AMR. The dynamics of AMR are significantly influenced by the diverse microbial phyla that make up the gut microbiota. Within the human gastrointestinal tract, ARGs are traded and transferred between various bacterial species quite often. This emphasizes how important it is that we understand how the human body functions on the inside as well as the outside sources of infections. ARGs could potentially come from the oral microbiota. Even in the absence of direct selection pressure, genes linked to AR can still be expressed there. The global epidemic of AR claims millions of lives and poses a serious risk to public health and the economy. Bacterial evolution, antibiotic overuse and misuse, genetically modified foods, and the spread of drug‐resistant pathogens through international travel are possibly contributing to AMR. Sustaining AMR requires surveillance, which is hampered by inadequate data collection, knowledge gaps, and low public awareness. In addition to raising death rates, AMR also raises healthcare costs, diminishes treatment effectiveness, and promotes the growth of drug‐resistant bacteria. Without considering agriculture, a knowledge gap, or the proper use of antibiotics, biological factors have contributed significantly to the escalation of AMR. This research summarizes the current knowledge and gaps on antimicrobial‐ and antibiotic‐resistant genes and the contribution of microbiota to AR.